BioCatalyst

GKOS — GLAUKOS Corp catalysts

1 verified catalyst event(s) for GLAUKOS Corp (ticker GKOS). Each is linked to its official source. Verified as of 2026-08-06.

Next verified catalyst

2026-09-01 — Evaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex Blepharitis · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-09 (month)
in 26d
ESTIMATED
 READOUT
Evaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex Blepha
Phase 2 · Demodex Blepharitis
 GKOS GLAUKOS Corp GLK-321 low dose BID, GLK-321 mid dose B ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.